Gynecologic Oncology

A new (theoretical) model using multiple data points, including genetic testing for BRCA genes, could identify women at greatest risk for breast cancer.

Studies of the impact of diet on risk of ovarian cancer are limited and their results unclear but a new report based on data from the Nurses’ Health Study (NHS) suggests a possible association between high intake of flavonoids and black tea and lower risk of the disease.

Voters in North Dakota sent a clear message that health care decisions, from pregnancy to end-of-life care, must involve only patients and their physicians.

Challenge your diagnostic skills: What's causing this woman's pelvic discomfort?

A consequence of Measure 1, which may or may not be a "personhood" amendment, is that IVF and other infertility services in North Dakota will end.

cfDNA gives insight into the pathogenesis of serious disease and early information about benign conditions.

Two experts discuss whether a DNA test can replace the Pap.

A new app, called ADNEX, helps distinguish between benign and malignant ovarian tumors, potentially improving triage and management decisions.

Breast cancer awareness campaigns are great, but they should be expanded to provide more clinician education on health disparities and to target women most at risk.

New research looking at complication rates and cost for oophorectomy and cystectomy favors conventional laparoscopy over robotic surgery.

According to a recent study, low-dose oral bisphosphonates administered to prevent or treat postmenopausal osteoporosis may be associated with a lower risk of skeletal metastasis in patients with early- or more advanced-stage breast cancer.

The tablet form of olaparib, given with chemotherapy, is promising in pretreated ovarian cancer patients with BRCA mutations, an investigational study finds.

When a jury sees a big corporation in the defendant’s chair, it can have an effect, although it is never a jury’s job to “punish” a corporation.

Challenge your diagnostic skills with these images of a pelvic mass.

Urine tests effectively screen for HPV, but more data is needed to determine whether they can correctly diagnose cervical disease.

Look no further: The North American Menopause Society has issued recommendations that offer the latest information for managing a woman's health through menopause.

Exposure to two common phenols, parabens and triclosans, may disrupt the growth of boys in utero and during their first years of life.

Are women with early-stage unilateral breast cancer misinformed about the survival benefit of removing both breasts vs lumpectomy with radiation?

Just in case your patients ever ask, wearing a bra is in no way associated with breast cancer risk.

Be it Pap tests, HPV tests, or both, cervical cancer screening is important. This article explores screening paradigms and offers a glimpse of what's to come.

An analysis of data from 46 states and the District of Columbia shows that the level of Medicaid reimbursement for office visits has an impact on likelihood of patient screening with Pap tests and other diagnostics for cancer.

A malpractice case hinges on an expert witness's testimony that a growing fibroid was not suspicious for cancer.

Despite earlier observational studies, bisphosphonate treatment for 3 to 4 years appears not to decrease the risk of invasive postmenopausal breast cancer, according to a new study in JAMA Internal Medicine.

According to a new study in Cancer Epidemiology Biomarkers & Prevention, brisk walking or vigorous exercise may help reduce risk of breast cancer in African-American women.

Avastin (bevacizumab) has been approved to treat patients with persistent, recurrent, or metastatic cervical cancer by the US Food and Drug Administration (FDA).